期刊
PEDIATRIC BLOOD & CANCER
卷 51, 期 6, 页码 784-786出版社
WILEY
DOI: 10.1002/pbc.21710
关键词
acute myeloid leukemia; children; respiratory syncytial virus
资金
- NCI NIH HHS [U10 CA098543-06, U10 CA098543, U10 CA098413-05] Funding Source: Medline
Background. Morbidity and mortality related to respiratory syncytial virus (RSV) in pediatric acute myeloid leukemia (AML) is not known. Procedure. We combined data from three Children's Oncology Group AML studies and determined the prevalence of RSV infection and RSV-related mortality in children treated for de novo AML. Results. We found that the prevalence of RSV infection ranged from 0% to 1% in induction and between 0.3 and 2.2% in consolidation. Four children died from RSV resulting in RSV-specific mortality of 0.2% among all children. However, the risk of RSV-related mortality among RSV infection episodes. was high (4/40, 10%). Conclusions. RSV infections and deaths are rare in pediatric AML. Pediatr Blood Cancer 2008;51:784-786. (c) 2008 Wiley-Liss, Inc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据